Creative Planning
LRMR icon

Creative Planning’s Larimar Therapeutics LRMR Stock Holding History

Creative Planning’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
116,801
+51,764
+80% +$206K ﹤0.01% 3437
2026
Q1 		$293K Buy
65,037
+29,419
+83% +$118K ﹤0.01% 3446
2025
Q4 		$136K Sell
35,618
-28,661
-45% -$111K ﹤0.01% 3656
2025
Q3 		$208K Buy
+64,279
New +$241K ﹤0.01% 3453

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Creative Planning's LRMR Position: Q2 2026 in Review

Creative Planning increased its Larimar Therapeutics (LRMR) stake by 80% in Q2 2026, buying an estimated $206K and bringing the position to 116,801 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #3437.

Creative Planning first reported a position in LRMR in Q3 2025 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Creative Planning held 116,801 shares of Larimar Therapeutics worth $356K as of Q2 2026.
  • Creative Planning bought 51,764 Larimar Therapeutics shares in Q2 2026, an estimated $206K.
  • Larimar Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3437 holding.
  • Creative Planning first reported a position in Larimar Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.